Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Abroad (travel likely)RecruitingPHASE3
Conditions
Coronary Artery Disease · Percutaneous Coronary Intervention · Acute Coronary Syndromes · Antiplatelet Therapy · Single Antiplatelet Therapy · Coagulation Factors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Istituto Cardiocentro Ticino, Lugano, Ch/ti, Switzerland
Contact: Study coordinator (Servizio di Ricerca Cardiovascolare Cardiocentro, +41 (0)91 811 53 04) · src.ICCT@eoc.ch
Study leads
Marco Valgimigli, Cardiology Chief Prof. Dr. Med
Principal Investigator
Cardiocentro Ticino